Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-controlled Study to Determine the Efficacy and Safety of 300 and 450 µg/Day Transdermal Testosterone in Female Patients With Low Ejection Fraction and Symptomatic Heart Failure

NCT00957034 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.

NCT NCT00957034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00957034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-controlled Study to Determine the Efficacy and Safety of 300 and 450 µg/Day Transdermal Testosterone in Female Patients With Low Ejection Fraction and Symptomatic Heart Failure
Lead sponsor
Warner Chilcott
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2009
Completion date
May 31, 2010
Enrollment
17 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure